BRE12-158: A post-neoadjuvant, randomized phase 2 trial of personalized therapy vs. treatment of physician's choice for patients with residual triple negative breast cancer Bryan P. Schneider , Guanglong Jiang , Tarah J. Ballinger , Fei Shen , Christopher Chitambar , Rita Nanda , Carla Falkson , Filipa C. Lynce , Christopher Gallagher , Claudine Isaacs , Marcelo Blaya , Elisavet Paplomata , Radhika Walling , Karen Daily , Reshma Mahtani , Michael A. Thompson , Robert Graham , Maureen E. Cooper , Dean C. Pavlick , Lee A. Albacker , Jeffery Gregg , Jeffery P. Solzak , Yu-Hsiang Chen , Casey L. Bales , Erica Cantor , Bradley A. Hancock , Nawal Kassem , Paul Helft , Bert O'Neil , Anna Maria Storniolo , Sunil Badve , Kathy D. Miller , Milan Radovich CANCER RESEARCH(2022)
AI 理解论文
溯源树
样例